rejuvant life tabs

Blood biomarkers of frailty: a paradigm for aging research

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

A recent meta-analysis identifies blood indicators as simple, non-invasive, economical and robust biomarkers of frailty.

Scientists at the Geriatrics Department of CHU Lille and Special Interest Group on Ageing Biology of European Geriatric Medicine Society (France) performed a meta-analysis and identified blood biomarkers associated with physical frailty. The results of this study paved the way for the discovery of circulating, robust biomarkers of aging and age-related diseases. The study was led by Aurélie Mailliez and overseen by Dr Éric Boulanger, and their findings were recently published in the journal Experimental Gerontology [1].

Longevity.Technology: Based on their physical condition, aging individuals are often classified as robust, frail or dependent. Frailty is a complex condition particularly common among the elderly. It is caused by dysfunction in numerous biological systems and is characterised by unintentional weight loss, fatigue, and physical and cognitive impairments [2, 3].

Given that frailty is reversible, early detection may enable clinicians to prevent its progression, or even reverse it. However, systematic frailty monitoring in routine clinical practice is hindered by the lack of reliable biomarkers of frailty and other age-related conditions [1].

Stages of aging. From Aurélie Mailliez et al., 2020.

“In the next five years there’s a critical need to be able to measure the validity of interventions without waiting for our whole lifespan. Right now, if we make an intervention that we think will increase lifespan we need to study it for twenty or thirty or forty years for an answer,” says Dr Eric Verdin, Chief Executive Officer, Buck Institute for Research on Aging [4]. “One solution is to develop biomarkers of aging. That is, we need to be able to assess whether a given person is aging well or aging poorly at a biological level.”

Elevant

In an effort to identify reliable biomarkers of frailty, Aurélie Mailliez and colleagues analysed the data of 67 studies including a total of 32,934 subjects and 6864 frail individuals. This comprehensive meta-analysis led to the identification of C-reactive protein (CRP), albumin, haemoglobin, 25-hydroxyvitamin D and free testosterone (in men) as the most reliable biomarkers of frailty [1].

Specifically, they found that the blood levels of CRP were significantly higher in frail individuals, whereas the circulating levels of albumin, haemoglobin, 25-hydroxyvitamin D, and free testosterone (in men) were significantly lower in the frail group [1].

Interestingly, circulating CRP and albumin are also included in the Levine/Cramer list of biomarkers of aging. The list includes nine blood indicators that can accurately estimate the phenotypic (biological) age. In addition to albumin and CRP, the Levine/Cramer list includes creatine, glucose, lymphocyte percent, mean cell volume, red blood cell distribution width, alkaline phosphatase, and white blood cell count [5].

Elevant

Mounting evidence suggests the potential value of CRP, albumin, haemoglobin, 25-hydroxyvitamin D, and free testosterone (in men) as simple, non-invasive, economical and robust biomarkers of frailty. Future clinical studies are required to confirm their potential value as a non-invasive clinical tool to screen for frailty and other age-related conditions.

[1] https://www.sciencedirect.com/science/article/pii/S0531556520303624?via=ihub
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028599/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2599957/
[4] https://bit.ly/3bAYa2R
[5] https://www.aging-us.com/article/101414/text

Image credit: uchschenF / Shutterstock
Christos Evangelou
Since the completion of his undergraduate and doctoral studies in Molecular Biosciences, Christos has been working in the medical communications industry, driven by his passion for communicating sciences. Apart from helping researchers to publish their studies, Christos writes articles related to sciences and medicine.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Muhdo partner with NUS in advanced longevity research

National University of Singapore and Muhdo Heath set to collaborate on an advanced global research project on longevity analysing epigenetic change. Muhdo Health announced today it...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

First non-invasive biomarker to track and verify senolytics

Researchers at The Buck Institute develop a biomarker test for senolytics, paving the way for senotherapeutic treatments. Buck Institute researchers have discovered and are developing...

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging. The new...

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...
Supps report ad middle